Thioredoxin-interacting protein and chronic lymphocytic leukemia

Leuk Lymphoma. 2012 Mar;53(3):492-4. doi: 10.3109/10428194.2011.607730. Epub 2011 Nov 15.
No abstract available

Publication types

  • Letter
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Aging / metabolism
  • Animals
  • Carrier Proteins / biosynthesis*
  • Carrier Proteins / genetics
  • Disease Progression
  • Female
  • Gene Expression Regulation, Leukemic
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics
  • Leukemia, Lymphocytic, Chronic, B-Cell / metabolism*
  • Male
  • Mice
  • Mice, Transgenic
  • Middle Aged
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics
  • RNA, Messenger / biosynthesis
  • RNA, Messenger / genetics
  • RNA, Neoplasm / biosynthesis
  • RNA, Neoplasm / genetics
  • Reactive Oxygen Species / metabolism
  • Up-Regulation

Substances

  • Carrier Proteins
  • Neoplasm Proteins
  • RNA, Messenger
  • RNA, Neoplasm
  • Reactive Oxygen Species
  • TXNIP protein, human